Physician Guide
Non-Opioid Intrathecal Therapy Pain Medication
IMPORTANT SAFETY INFORMATION
WARNING: NEUROPSYCHIATRIC ADVERSE REACTIONS
PRIALT is contraindicated in patients with a preexisting history of psychosis. Severe psychiatric symptoms and neurological impairment may occur during treatment with PRIALT. Monitor all patients frequently for evidence of cognitive impairment, hallucinations, or changes in mood or consciousness. Discontinue PRIALT therapy in the event of serious neurological or psychiatric signs or symptoms.

Patient Counseling and Setting Expectations with PRIALT

Page 1 of 2

In this video presentation, Dr. Gladstone C. McDowell, II* explains important topics for discussion with your patients, including patient counseling and setting expectations. Dr. McDowell is the Medical Director of Integrated Pain Solutions in Columbus, Ohio.
 

 

Key Takeaway Points

Patient counseling, including setting patient expectations, is an important component to the initiation of PRIALT therapy. Inform your patients that PRIALT, a non-opioid medication, is a well-studied IT medication that is approved by the FDA for the treatment of severe chronic pain in adults. Patients should understand that it may take some time to achieve adequate pain relief. Finding the effective dose is an ongoing process tailored to the individual patient’s response, severity of pain, as well as side effects.

*Gladstone C. McDowell, II, MD is a paid consultant for Jazz Pharmaceuticals.

Last updated on: April 18, 2018
SHOW MAIN MENU
SHOW SUB MENU